Unique ID issued by UMIN | UMIN000032002 |
---|---|
Receipt number | R000036418 |
Scientific Title | Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma |
Date of disclosure of the study information | 2018/04/01 |
Last modified on | 2023/05/18 17:50:52 |
Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma
Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma(FOREST)
Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma
Follicular lymphoma in Japan: a prospective cohort study of newly-diagnosed patients with follicular lymphoma(FOREST)
Japan |
Follicular lymphoma
Hematology and clinical oncology |
Malignancy
NO
To elucidate the clinical presentation, pathological classifications, pattern of initial management, and outcomes in patients with newly diagnosed follicular lymphoma in Japan.
Others
Clinical presentation, pathological classifications, pattern of initial management, outcomes
Overall survival from diagnosis date
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Newly-diagnosed follicular lymphoma (Grade 1, 2, 3A, and 3B).
2) Treatment or follow-up is being scheduled at a participating hospital.
3) Aged 20 or over.
4) Written informed consent.
1) Past history of any type of malignant lymphoma.
2) Follicular lymphoma with diffuse large B-cell lymphoma.
3) Transformed follicular lymphoma.
1000
1st name | Koji |
Middle name | |
Last name | Izutsu |
National Cancer Center Hospital
Department of Hematology
104-0045
5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
03-3542-2511
TRIML1620@tri-kobe.org
1st name | Wataru |
Middle name | |
Last name | Munakata |
National Cancer Center Hospital
Department of Hematology
104-0045
5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
03-3542-2511
TRIML1620@tri-kobe.org
The Japanese Society for Lymphoreticular Tissue Research(JSLTR)
Eisai Co., Ltd
Chugai Pharmaceutical Co., Ltd.
Profit organization
National Cancer Center Institutional Review Board
5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
03-3542-2511
NCC_IRBoffice@ml.res.ncc.go.jp
NO
2018 | Year | 04 | Month | 01 | Day |
Unpublished
1120
No longer recruiting
2018 | Year | 02 | Month | 14 | Day |
2018 | Year | 02 | Month | 21 | Day |
2018 | Year | 04 | Month | 01 | Day |
2028 | Year | 02 | Month | 29 | Day |
1)Prospective Cohort study
2)Patients who satisfy selection criteria, do not meet exclusion criteria, and provide written informed consent.
3)the clinical presentation including clinical stage, tumor burden, and prognostic factors, pathological classifications, pattern of initial management, outcomes.
2018 | Year | 03 | Month | 30 | Day |
2023 | Year | 05 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036418
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |